Article title: Cetuximab-modified silica nanoparticle loaded with ICG for tumor-targeted combinational therapy of breast cancer
Authors: Zhang, X., Li, Y., Wei, M., Liu, C., Yu, T., and Yang, J.
Journal: Drug Delivery
Bibliometrics: Volume 26, Number 1, pages 129–136
DOI: https://doi.org/10.1080/10717544.2018.1564403
Professor Tao Yu has been added as an author of this article for the following reasons:
Prof. Tao Yu contributed to the design and data analysis in the early stage of the study, and made substantial contributions to the writing and submission stage, including the discovery of errors in the author's information in the original text, so all our authors agreed that Prof. Yu should be added as the coauthor of this article.
In the preparation of Cet-SLN/ICG, Cet-SLN was suspended in water (2 mg/mL), and indigo green (0.5 mL, 2 mg/mL) was added drop by drop, and stirred gently. Thirty minutes after incubation, the mixture was treated by a probe-type ultrasound generator (VCX130PB, Sonics, USA) provided by Prof. Tao Yu.
We confirm that Tao Yu meets the International Committee of Medical Journal Editors (ICMJE) requirements for authorship (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html).